Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Press Releases
Crown Laboratories, Inc.  
February 5, 2025

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

JOHNSON CITY, Tenn. and NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVNC) ("Revance"), today announced that the tender offer to purchase

avatar profile Olean Times Herald

Olean Times Herald


Local & Social